BLUEJET575.00

Blue Jet Healthcare Ltd.

· Pharma & Health
₹ CrorePeersDIVISLABAARTIPHARMCAPLIPOINTACUTAASCONCORDBIOEMCUREERISGRANULES
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation28.117.8
+ Finance Costs0.20.1
+ Interest Income-1.7-5.1
Changes in Working Capital
+ Inventories-4.2-134.1
+ Trade Receivables — Current64.0-169.5
+ Trade Payables — Current-12.748.4
Cash from Operating Activities
Profit Before Tax (per I/S)315.6
Cash from Operations (pre-tax)13.2-262.8
+ Income Taxes Paid11.189.0
Cash from Operating Activities241.345.8
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)172.979.9
+ Disp of Fixed Assets0.70.4
+ Purchase of Investments (Equity / Debt)86.385.3
+ Interest Received — Investing0.45.2
Cash from Investing Activities-263.8-35.2
Cash from Financing Activities
+ Interest Paid0.1
Cash from Financing Activities-2.0-18.6
Net Changes in Cash-24.5-8.0
Closing Cash41.033.0
Reference Items
EBITDA271.2
EBITDA Margin %30.62
Free Cash Flow (CFO − Capex)68.4-34.1-34.1
Cash Paid for Taxes11.189.0
Cash Paid for Interest0.1
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 97%.